Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies.

Kariyawasam HH.

Expert Rev Clin Immunol. 2018 Oct 27:1-13. doi: 10.1080/1744666X.2019.1541738. [Epub ahead of print]

PMID:
30370785
2.

Omalizumab treats chronic rhinosinusitis with nasal polyps and asthma together-a real life study.

Bidder T, Sahota J, Rennie C, Lund VJ, Robinson DS, Kariyawasam HH.

Rhinology. 2018 Mar 1;56(1):42-45. doi: 10.4193/Rhin17.139.

PMID:
29288573
3.

Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited.

Samitas K, Carter A, Kariyawasam HH, Xanthou G.

Allergy. 2018 May;73(5):993-1002. doi: 10.1111/all.13373. Epub 2017 Dec 22. Review.

PMID:
29197105
4.

Phase three studies of biologics for severe asthma: could do better?

Robinson DS, Kariyawasam HH, Heaney LG.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701108. doi: 10.1183/13993003.01108-2017. Print 2017 Sep. No abstract available.

PMID:
28899938
5.

Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

Bachert C, Sousa AR, Lund VJ, Scadding GK, Gevaert P, Nasser S, Durham SR, Cornet ME, Kariyawasam HH, Gilbert J, Austin D, Maxwell AC, Marshall RP, Fokkens WJ.

J Allergy Clin Immunol. 2017 Oct;140(4):1024-1031.e14. doi: 10.1016/j.jaci.2017.05.044. Epub 2017 Jul 4.

6.

BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).

Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, Durham SR, Farooque S, Jones N, Leech S, Nasser SM, Powell R, Roberts G, Rotiroti G, Simpson A, Smith H, Clark AT.

Clin Exp Allergy. 2017 Jul;47(7):856-889. doi: 10.1111/cea.12953.

PMID:
30239057
7.

Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.

Chen JB, James LK, Davies AM, Wu YB, Rimmer J, Lund VJ, Chen JH, McDonnell JM, Chan YC, Hutchins GH, Chang TW, Sutton BJ, Kariyawasam HH, Gould HJ.

J Allergy Clin Immunol. 2017 Apr;139(4):1195-1204.e11. doi: 10.1016/j.jaci.2016.06.066. Epub 2016 Sep 19.

8.

Activin-A is overexpressed in severe asthma and is implicated in angiogenic processes.

Samitas K, Poulos N, Semitekolou M, Morianos I, Tousa S, Economidou E, Robinson DS, Kariyawasam HH, Zervas E, Corrigan CJ, Ying S, Xanthou G, Gaga M.

Eur Respir J. 2016 Mar;47(3):769-82. doi: 10.1183/13993003.00437-2015. Epub 2016 Feb 11.

9.

IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa.

Lam EP, Kariyawasam HH, Rana BM, Durham SR, McKenzie AN, Powell N, Orban N, Lennartz-Walker M, Hopkins C, Ying S, Rimmer J, Lund VJ, Cousins DJ, Till SJ.

J Allergy Clin Immunol. 2016 May;137(5):1514-24. doi: 10.1016/j.jaci.2015.10.019. Epub 2015 Dec 10.

10.

Mepolizumab for eosinophilic severe asthma: recent studies.

Robinson DS, Kariyawasam HH.

Expert Opin Biol Ther. 2015 Jun;15(6):909-14. doi: 10.1517/14712598.2015.1041911. Epub 2015 May 8. Review.

PMID:
25951938
11.

Allergic rhinitis, chronic rhinosinusitis and asthma: unravelling a complex relationship.

Kariyawasam HH, Rotiroti G.

Curr Opin Otolaryngol Head Neck Surg. 2013 Feb;21(1):79-86. doi: 10.1097/MOO.0b013e32835ac640. Review.

PMID:
23241653
12.

Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps.

Gevaert P, Nouri-Aria KT, Wu H, Harper CE, Takhar P, Fear DJ, Acke F, De Ruyck N, Banfield G, Kariyawasam HH, Bachert C, Durham SR, Gould HJ.

Allergy. 2013 Jan;68(1):55-63. doi: 10.1111/all.12054. Epub 2012 Nov 15.

PMID:
23157682
13.

Chronic rhinosinusitis: therapeutic efficacy of anti-inflammatory and antibiotic approaches.

Kariyawasam HH, Scadding GK.

Allergy Asthma Immunol Res. 2011 Oct;3(4):226-35. doi: 10.4168/aair.2011.3.4.226. Epub 2011 Sep 1.

14.

The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge.

Nicholson GC, Kariyawasam HH, Tan AJ, Hohlfeld JM, Quinn D, Walker C, Rodman D, Westwick J, Jurcevic S, Kon OM, Barnes PJ, Krug N, Hansel TT.

J Allergy Clin Immunol. 2011 Oct;128(4):800-807.e9. doi: 10.1016/j.jaci.2011.05.013. Epub 2011 Jun 29.

PMID:
21719078
15.

Activin-A: a novel critical regulator of allergic asthma.

Kariyawasam HH, Semitekolou M, Robinson DS, Xanthou G.

Clin Exp Allergy. 2011 Nov;41(11):1505-14. doi: 10.1111/j.1365-2222.2011.03784.x. Epub 2011 Jun 1. Review.

PMID:
21631612
16.

Expression of functional receptor activity modifying protein 1 by airway epithelial cells with dysregulation in asthma.

Bonner K, Kariyawasam HH, Ali FR, Clark P, Kay AB.

J Allergy Clin Immunol. 2010 Dec;126(6):1277-83.e3. doi: 10.1016/j.jaci.2010.08.013. Epub 2010 Oct 8.

PMID:
20933260
17.
18.

Developments in the field of allergy in 2008 through the eyes of Clinical & Experimental Allergy.

Almqvist C, Bradding PB, Chakir J, Ebo D, Grattan C, Kariyawasam HH, Savilahti E, Scadding GK, Vieths S, Wardlaw AJ, Woodfolk J.

Clin Exp Allergy. 2009 Oct;39(10):1482-98. doi: 10.1111/j.1365-2222.2009.03355.x. Review.

PMID:
19954428
19.

Airways disease: just nosing around?

Scadding GK, Kariyawasam HH.

Thorax. 2009 Nov;64(11):923-5. doi: 10.1136/thx.2009.125047. No abstract available.

PMID:
19864539
20.

Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma.

Kariyawasam HH, Pegorier S, Barkans J, Xanthou G, Aizen M, Ying S, Kay AB, Lloyd CM, Robinson DS.

J Allergy Clin Immunol. 2009 Sep;124(3):454-62. doi: 10.1016/j.jaci.2009.06.022.

Supplemental Content

Loading ...
Support Center